Loss of power from an optimistic alternative hypothesis

Area of Science:

• Clinical Trials
• Biostatistics
• Medical Research

Background:

• Clinical trial sample size calculations often assume a minimum expected treatment difference to achieve desired statistical power.
• Investigators may inflate this assumed difference to obtain a practicable sample size, risking the detection of smaller, yet clinically significant, treatment effects.

Purpose of the Study:

• To derive an expression for the loss of statistical power in clinical trials when the true treatment difference is less than the minimum difference assumed during sample size planning.
• To develop a method for calculating expected power by incorporating a prior distribution for the fractional difference between the assumed and true treatment effects.

Main Methods:

• Derived a formula for power loss that is independent of sample size and response rates, depending primarily on the fractional difference between the assumed and true treatment effects.
• Proposed using a prior distribution (e.g., beta distribution) for this fractional difference to calculate the expected power of a clinical trial.

Main Results:

• The derived expression quantifies the reduction in statistical power when the actual treatment effect is smaller than the one used for sample size determination.
• The method allows for a more realistic estimation of a study's power by accounting for uncertainty in the true treatment difference.

Conclusions:

• The proposed method offers a practical approach to assess and potentially improve the accuracy of clinical trial power calculations.
• This framework helps mitigate the risk of missing clinically important findings due to overly optimistic assumptions about treatment effects in trial design.